Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Functional Analysis of Bone Mineral Density (BMD) Variants in Osteoblasts with CRISPR Prime Editing

EF 2024-25

Résumé
Osteoporosis is a skeletal disorder marked by reduced bone mineral density (BMD) and increased fracture risk, leading to disability and diminished quality of life. In Canada, 2 million individuals are affected, significantly contributing to healthcare costs. While genome-wide association studies (GWAS) have identified genetic variants linked to BMD, most reside in non-coding regions, making it challenging to understand their role in bone biology, hindering the development of new therapeutics. In my research, I will address the variant-to-function (V2F) problem by developing a human osteoblast cell line with CRISPR prime editing to precisely insert BMD-associated variants into the osteoblast genome and observed their functional impact. To do this, my first aim is to clone the most recent CRISPR prime editor, PE7, into a lentiviral plasmid and transduce into immature human osteoblasts. These cells are ideal for my project since they differentiate to mature osteoblasts with mineralizing activity, providing a way to directly observe bone mineralization as a result of variant insertion. After the prime editing cell line is successfully established, I will take the predicted causal BMD-associated variants from the largest BMD GWAS to-date and identify which variants map back to regulatory elements in the chromatin. I will take the top 280 variants and insert them in the osteoblast genome using CRISPR prime editing followed by single cell gene expression analysis to reveal gene expression changes linked to each target variant. This will generate a list of most causal and functional BMD-associated variants which can be subsequently tested for their impact on bone mineralization and can serve as a starting point to identify candidate therapeutic targets for osteoporosis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529678
Name
Pitas Hannah
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Functional Analysis of Bone Mineral Density (BMD) Variants in Osteoblasts with CRISPR Prime Editing
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atac-Seq; Bone Mineral Density; Crispr Prime Editing; Functional Genomics; Gene Regulation; Genome Wide Association Studies; Non-Coding Genetic Variants; Osteoporosis; Single-Cell Rna-Seq; Variant-To-Function
Abstract
Osteoporosis is a skeletal disorder marked by reduced bone mineral density (BMD) and increased fracture risk, leading to disability and diminished quality of life. In Canada, 2 million individuals are affected, significantly contributing to healthcare costs. While genome-wide association studies (GWAS) have identified genetic variants linked to BMD, most reside in non-coding regions, making it challenging to understand their role in bone biology, hindering the development of new therapeutics. In my research, I will address the variant-to-function (V2F) problem by developing a human osteoblast cell line with CRISPR prime editing to precisely insert BMD-associated variants into the osteoblast genome and observed their functional impact. To do this, my first aim is to clone the most recent CRISPR prime editor, PE7, into a lentiviral plasmid and transduce into immature human osteoblasts. These cells are ideal for my project since they differentiate to mature osteoblasts with mineralizing activity, providing a way to directly observe bone mineralization as a result of variant insertion. After the prime editing cell line is successfully established, I will take the predicted causal BMD-associated variants from the largest BMD GWAS to-date and identify which variants map back to regulatory elements in the chromatin. I will take the top 280 variants and insert them in the osteoblast genome using CRISPR prime editing followed by single cell gene expression analysis to reveal gene expression changes linked to each target variant. This will generate a list of most causal and functional BMD-associated variants which can be subsequently tested for their impact on bone mineralization and can serve as a starting point to identify candidate therapeutic targets for osteoporosis.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pitas, Hannah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~